FDA Panel Chair Targeted Over Advice To Drug Cos.

Law360, New York (October 24, 2013, 7:44 PM EDT) -- Consumer group Public Citizen on Thursday urged a U.S. Food and Drug Administration advisory committee chairwoman to cancel a speaking engagement aimed at advising pharmaceutical companies, a request that seemed likely to be granted after she chastised event organizers for promoting her appearance excessively.

In a letter to FDA Commissioner Margaret Hamburg, the group criticized a scheduled appearance by Lynn Drake, head of a committee on skin and eye drugs, at a February conference called Summit on FDA Advisory Committee Prep.

Lynn’s topic, according to a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.